SEATTLE — Early in the pandemic, many people seized on the hope that Covid-19 could be stopped in its tracks and buried for good once vaccines rolled out.
But hope for a zero-Covid country fizzled for most scientists long ago.
“Everyone has stopped talking about getting rid of Covid,” Dr. Elizabeth Halloran, an epidemiologist at the Fred Hutchinson Cancer Research Center in Seattle, said of her fellow researchers. “It’s not going away, and that means it’s going to be endemic.”
Three separate teams of scientists on two continents have found that Omicron infections more often result in mild illness than earlier variants of the coronavirus, offering hope that the current surge may not be quite as catastrophic as feared despite skyrocketing caseloads.
The researchers examined Omicron’s course through populations in South Africa, Scotland and England. The results in each setting, while still preliminary, all suggested that the variant was less likely to send people in hospitals.
“Given that this is everywhere and given that it’s going to be so transmissible, anything that would lower severity is going to be better,” said Natalie Dean, a biostatistician at Emory University in Atlanta.
The Supreme Court will hear legal challenges to the Biden administration's employer vaccine mandates next month, the justices announced Wednesday night, setting a rapid schedule for the cases.
(CNN) Two new preprint papers add to the growing evidence that the Omicron coronavirus variant may be less likely to cause severe disease and hospitalization compared to the Delta variant.
WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
Recent Comments